Skip to main content

Table 1 Distribution of S. aureus isolates

From: Staphylococcus aureus with inducible clindamycin resistance and methicillin resistance in a tertiary hospital in Nepal

 

Culture positive (%)

Gram-positive bacteria (%)

S. aureus (%)

MRSA (%)

Clinical specimen

 Urine (n = 859)

225 (26.0%)

22 (9.8%)

8 (3.5%)

3 (37.5)

 Pus (n = 52)

41 (78.8%)

32 (78.5%)

16 (39.2%)

8 (50%)

 Blood (n = 50)

21 (42%)

9 (42.9%)

4 (19.1%)

1 (25%)

 Sputum (n = 41)

23 (56.1%)

14 (60.9%)

6 (26.1%)

2 (33.3%)

 *Body fluids (n = 25)

17 (68.0%)

5 (29.41%)

4 (23.5%)

1 (25%)

Hospital care for patients

 Outpatient care (n = 752)

215 (28.5%)

49 (22.8%)

21 (9.8%)

8(38.0%)

 Inpatient care (n = 275)

107 (38.9%)

33 (12%)

17 (15.8%)

7 (41.1%)

Sex of patients

 Male (n = 400)

109 (27.3%)

36 (33.0%)

18 (16.5%)

9 (50%)

 Female (n = 627)

212 (33.81%)

46 (21.7%)

20 (9.4%)

6 (30%)

 Total (n = 1027)

321 (31.3%)

82 (25.5%)

38 (11.8%)

15 (39.4%)

  1. S. aureus; *body fluids = CSF, synovial fluid, pleural fluid, throat swabs, vaginal swabs; percentage calculated on respective row total of preceding columnsIn susceptibility testing, all isolates of S. aureus were susceptible to vancomycin and 33 (86.8%) were susceptible to amikacin. All isolates were resistant to penicillin-G and ampicillin (Table 2). Also, 25 (67.5%) of S. aureus were MDR. Of 38 S. aureus, 19 (50%) were screened as MRSA, of which, 15 (39.4%) were confirmed MRSA phenotypically
  2. MRSA methicillin-resistant
Back to article page